Pediatrix Medical Group, Inc. 8-K
Research Summary
AI-generated summary
Pediatrix Medical Group Reports Q4 and Full‑Year 2025 Results
What Happened
Pediatrix Medical Group, Inc. (MD) filed a Form 8‑K on February 19, 2026 (Item 2.02) to announce its results of operations for the three months and twelve months ended December 31, 2025. The company issued a press release dated February 19, 2026 detailing those quarterly and full‑year results; that release is attached to the 8‑K as Exhibit 99.1.
Key Details
- Filing date: February 19, 2026 (Form 8‑K, Item 2.02).
- Period covered: three months and twelve months ended December 31, 2025.
- Press release attached as Exhibit 99.1 and incorporated by reference; Inline XBRL cover page included (Exhibit 104).
- Report signed on behalf of the company by Kasandra H. Rossi, Chief Financial Officer.
Why It Matters
This 8‑K signals the company has publicly released its Q4 2025 and full‑year 2025 financial results. Retail investors should review the attached press release (Exhibit 99.1) for the specific figures—revenue, earnings, and any commentary on trends or guidance—because those items directly affect valuation and near‑term trading decisions.